Compared to clusters 1 and 3, cluster 2 was obviously enriched in stromal and cancer-related pathways, comprising TGF-β, MARK, cell adhesion, Notch, and JAK/STAT signaling pathways (Figure 4A–C, Tables S3–S5). The gene discussed is MARK1; the disease is cancer.